Clinical Trials on Blood Coagulation Tests in Switzerland

Total 2453 results

University Hospital Inselspital, Berne
University of Bern

Completed

Non-inferiority Study for Visual Field Measurements Using a Virtual Reality Device

Visual Field Tests

Switzerland
University of Zurich

Completed

Changing Vertical Self-motion Perception

Vestibular Function Tests

Switzerland
Triemli Hospital
University of Zurich

Completed

Blood Transfusion and Postoperative Outcome Before and After Implementing a Coagulation Management Algorithm (SONALG)

Coagulation Disorder, Blood

Switzerland
University Hospital Inselspital, Berne

Completed

Impact of Non-invasive Positive Pressure Ventilation on Cardiac Function and Echocardiographic Parameters

Noninvasive Ventilation | Hemodynamics | Heart Function Tests | Circulatory and Respiratory Physiological Phenomena

Switzerland
Walid HABRE

Completed

PSV on Ventilation Inhomogeneity and Lung Function in Patients Under SB Across LMA (VINHO)

Anesthesia, General | Ventilation | Respiratory Function Tests | Patient Positioning

Switzerland
University of Zurich

Recruiting

Blood Loss and Preeclampsia

Blood Loss | Coagulation Disorder | Pre-Eclampsia; Complicating Pregnancy

Switzerland
University of Zurich

Completed

Validation of Thrombelastometry (ROTEM®)

Coagulation

Switzerland
Bayer

Completed

International PMS Study - KOGENATE Bayer

Hemophilia A

Switzerland, France, Spain, Sweden, Austria, Italy, Belgium, Denmark, Greece, Netherlands
University Hospital, Basel, Switzerland

Completed

Acquired Von Willebrand Syndrome in Severe Aortic Stenosis

Bleeding | Aortic Stenosis | Von Willebrand Disease

Switzerland
University Hospital, Geneva
Swiss Hemophilia Network

Completed

Pregnancy and Fibrinogen Disorders (FIBRINOGEST)

Hypofibrinogenemia, Congenital | Afibrinogenemia, Congenital | Dysfibrinogenemia, Congenital

Switzerland, France, Slovakia
Centre Hospitalier Universitaire Vaudois

Completed

Bedside Evaluation of Coagulation in Children With Congenital Heart Disease (POCHEMO)

Blood Coagulation Disorder | Congenital Heart Defect

Switzerland
University of Zurich

Completed

Hemodilution and Coagulopathy With 3 Colloids

Dilutional Coagulopathy

Switzerland
University Hospital, Geneva

Completed

Standardisation of Investigations of Mild Bleeding Disorders (MBD)

Hemorrhagic Disorders

Switzerland
University Children's Hospital, Zurich

Completed

Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study.

Hemorrhage | Blood Coagulation Disorders

Switzerland
University of Lausanne

Completed

Fructose Extra-splanchnic Metabolism and Its Effects on Systemic Flux of Substrates (FruPP) (FruPP)

Test Meal

Switzerland
University Hospital, Basel, Switzerland
Prof. Dr., Jens Gaab, Division of Clinical Psychology and Psychotherapy,... and other collaborators

Completed

Taking Open Label Placebo Further: Trial of Imaginary Pills in Test Anxiety

Test Anxiety

Switzerland
Prof. Dominique de Quervain, MD

Completed

Influence of Chocolate With Plant Additives on Episodic Memory in Healthy Subjects Experiencing Test Anxiety (MaRS-Basel)

Test Anxiety

Switzerland
University Hospital, Geneva

Recruiting

Bleeding of Unknown Cause: a Swiss Case-control Study (SWISS-BUC)

Bleeding Disorder

Switzerland
University Hospital, Geneva

Completed

DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic (DAPHNE)

Anticoagulants and Bleeding Disorders

Switzerland
Swiss Hemophilia Network

Recruiting

Swiss Hemophilia Registry

Hemophilia and Other Severe Bleeding Disorders

Switzerland
Pfizer

Completed

PF-06741086 Multiple Dose Study in Severe Hemophilia

Hemophilia A or B

United States, Chile, Croatia, Poland, South Africa, Switzerland
Klinik Barmelweid

Completed

Exploration of Possible Reasons for the Discrepancy Between Expectation and Indication of Subjective Perceived Exertions (Ex-6-rate)

Coronary Disease | Cardiac Rehabilitation | Physical Therapy | Physical Exertion | Exercise Test

Switzerland
Novo Nordisk A/S

Completed

Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects

Congenital Bleeding Disorder | Haemophilia A

Spain, Germany, Switzerland, Italy, Israel
Genzyme, a Sanofi Company

Completed

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

Hemophilia A | Hemophilia B

Bulgaria, United States, United Kingdom, Russian Federation, Switzerland
University Hospital, Geneva

Unknown

Functional Outcome After Incisional Hernia Repair: Open Versus Laparoscopic Repair (GINCISHERNIA)

Quality of Life | Hernia, Ventral | Body Image | Laparoscopy | Respiratory Function Tests

Switzerland
University Hospital, Basel, Switzerland

Completed

Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery

Blood Coagulation Disorders | Coronary Artery Bypass Graft Triple Vessel

Switzerland
Sanofi

Completed

A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

Hemophilia A | Hemophilia B

Bulgaria, Switzerland, United Kingdom, United States, Russian Federation
Pfizer

Completed

PF-06741086 Long-term Treatment in Severe Hemophilia

Hemophilia A or B

Poland, Switzerland, South Africa, United States, Croatia, Brazil, Chile
Octapharma

Completed

Pharmacokinetic, Efficacy, and Safety Study of Octafibrin Compared to Haemocomplettan/Riastap

Congenital Fibrinogen Deficiency | Afibrinogenemia

Iran, Islamic Republic of, United States, Bulgaria, India, Switzerland, United Kingdom
Ospedale Regionale di Mendrisio

Recruiting

Virtual Reality Mindfulness in Preoperative Anxious Patients

Anxiety State | Test Anxiety | Preoperative Period

Switzerland
Swedish Orphan Biovitrum
Cerner Enviza

Completed

rFVIIIFc (Elocta®) ITI Chart Review in Patients With Haemophilia A

Hemophilia A With Inhibitor

France, Ireland, Italy, Norway, Germany, Kuwait, Saudi Arabia, Switzerland
Kantonsspital Winterthur KSW

Terminated

Ghrelintrial With Patients With Stroke

Stroke, Acute | DEMMMI, Nine-Hole-PEG-Test, mRS

Switzerland
Tem Innovations GmbH

Unknown

ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference Intervals (ROSI-EVA)

Blood Coagulation Disorders

United States, Austria, Switzerland
University Hospital Inselspital, Berne

Completed

Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC) (RheoMECC)

Inflammation | Intracranial Embolism | Extracorporeal Circulation | Blood Coagulation

Switzerland
Novo Nordisk A/S

Enrolling by invitation

A Study Following Males With Haemophilia A on Prophylaxis With Esperoct® (pathfinder9)

Haemophilia A

Austria, Spain, Bulgaria, Croatia, Estonia, Hungary, Italy, Lithuania, Portugal, Greece, Germany, Czechia, Slovenia, Switzerland, Slovakia
Bayer

Active, not recruiting

Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A (HEM-POWR)

Hemophilia A

Canada, Japan, Spain, United States, Germany, Sweden, Belgium, Brazil, Greece, Italy, Netherlands, Taiwan, Denmark, Kuwait, Saudi Arabia, United Arab Emirates, Norway, Colombia, Switzerland, Slovenia
Baxalta now part of Shire

Completed

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

Hemophilia A

United States, Spain, Netherlands, United Kingdom, Bulgaria, Lithuania, Russian Federation, Switzerland, Ukraine
CSL Behring

Completed

Quality of Life Study of Helixate NexGen

Hemophilia A

Austria, Belgium, France, Germany, Italy, Spain, Switzerland
Dr Yan Beauverd

Completed

Treatment of Polycythaemia Vera and Essential Thrombocythaemia: Influence on the Clot Structure (MPNClot)

Polycythemia Vera | Thrombocythemia, Essential

Switzerland, United Kingdom
Swedish Orphan Biovitrum

Active, not recruiting

A 48-Month Study to Evaluate Long-Term Effectiveness of Elocta on Joint Health (A-MORE)

Hemophilia A

Spain, Germany, Czechia, Italy, Estonia, Finland, Greece, Netherlands, Saudi Arabia, Slovenia, Sweden, Switzerland, United Kingdom
Novo Nordisk A/S

Completed

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B (paradigm™7)

Congenital Bleeding Disorder | Haemophilia B

United States, Switzerland, Germany
University Hospital, Basel, Switzerland

Recruiting

Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia (BASEL VIII)

Coronary Artery Disease | Angina, Stable | Biological Markers | Exercise Test | SPECT

Switzerland
Novo Nordisk A/S

Completed

A Research Study Investigating Mim8 in People With Haemophilia A (FRONTIER1)

Healthy Volunteers | Haemophilia A With or Without Inhibitors

United States, Germany, Spain, Austria, Bulgaria, Italy, Japan, South Africa, Switzerland, Turkey, United Kingdom, Poland
University Hospital, Geneva

Completed

Quality of Life in Patients With Congenital Afibrinogenemia (QualyAFIB)

Afibrinogenemia, Congenital

France, Turkey, Switzerland, Netherlands, Spain, India, Poland, Canada, United States, Algeria, Egypt, Germany, Italy, Japan, Kuwait, Lebanon, Morocco, Pakistan, Serbia, Slovakia, Tunisia
CSL Behring

Completed

Pharmacokinetic, Efficacy, and Safety Study of Recombinant Factor VIII Single Chain (rVIII-SingleChain) in Children With Severe Hemophilia A

Congenital Hemophilia A

United States, Austria, Germany, Malaysia, Netherlands, Philippines, Ukraine, Romania, Spain, Australia, France, Georgia, Italy, Lebanon, Poland, Portugal, Switzerland, Thailand, Turkey
Bioverativ, a Sanofi company

Completed

Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A (XTEND-Kids)

Hemophilia A

Turkey, Australia, Canada, France, Germany, Hungary, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
Novo Nordisk A/S

Completed

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B (Explorer 1)

Healthy | Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

Austria, Sweden, Spain, Switzerland, United Kingdom, Germany, Malaysia, Denmark, South Africa, Thailand, Italy
Novo Nordisk A/S

Completed

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A (pathfinder™1)

Congenital Bleeding Disorder | Haemophilia A

United States, Germany, Switzerland, United Kingdom, Italy, Japan, Turkey
Novo Nordisk A/S

Recruiting

A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors

Haemophilia A With or Without Inhibitors

Korea, Republic of, India, China, Canada, Spain, Netherlands, South Africa, United States, Israel, Japan, Poland, United Kingdom, Italy, Lithuania, Portugal, Switzerland, Taiwan
University Children's Hospital Basel
Novartis Pharmaceuticals; Stiftung zur Förderung medizinischer und biologischer... and other collaborators

Active, not recruiting

Immunomodulation With Eltrombopag in ITP (iROM2)

Primary Immune Thrombocytopenia (ITP)

Switzerland

Clinical Trials on Blood Coagulation Tests in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations